ZBH
65
3
F
56
-3
RIG
43
-7
PBI
56
-2
HRL
35
-3
MCD
52
-5
HST
39
-3
XOM
42
-6
MSFT
46
-11
TXN
43
-5
STT
64
2
AMGN
42
-4
CB
57
2
SCHW
62
-2
SWKS
38
-2
LB
30
4
RRC
52
-6
BA
47
2
URI
60
-6
UAL
83
-2
ZBH
65
3
F
56
-3
RIG
43
-7
PBI
56
-2
HRL
35
-3
MCD
52
-5
HST
39
-3
XOM
42
-6
MSFT
46
-11
TXN
43
-5
STT
64
2
AMGN
42
-4
CB
57
2
SCHW
62
-2
SWKS
38
-2
LB
30
4
RRC
52
-6
BA
47
2
URI
60
-6
UAL
83
-2
Financhill
Back

T. Rowe Price Blue Chip Growth ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
76

TCHP
T. Rowe Price Blue Chip Growth ETF

Last Price:
41.10
Seasonality Move:
3.62%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
76
T. Rowe Price Blue Chip Growth ETF (TCHP) is a Buy

Is T. Rowe Price Blue Chip Growth ETF a Buy, Sell or Hold?

  • The current T. Rowe Price Blue Chip Growth ETF [TCHP] share price is $41.08. The Score for TCHP is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • TCHP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TCHP Stock Price Chart

What is T. Rowe Price Blue Chip Growth ETF's stock price today?

  • The T. Rowe Price Blue Chip Growth ETF share price today is $41.08
    The current trend is moderately bearish and TCHP is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

TCHP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.56 Buy
Relative Strength Index (14 RSI): 52.1 Buy
Chaikin Money Flow: -70072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.09 - 41.71) Buy
Bollinger Bands (100): (37.55 - 40.63) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

TCHP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.95 Sell
20-day SMA: 41.04 Buy
50-day SMA: 40.03 Buy
200-day SMA: 37.26 Buy
8-day EMA: 41.66 Sell
20-day EMA: 41.15 Sell
50-day EMA: 40.22 Buy
200-day EMA: 37.05 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

T. Rowe Price Blue Chip Growth ETF Earnings Growth & TCHP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

T. Rowe Price Blue Chip Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):